Genital Neoplasms, Female  >>  Pexa-Vec (pexastimogene devacirepvec)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pexa-Vec (pexastimogene devacirepvec) / SillaJen, Transgene
NCT02017678: Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin

Withdrawn
2
0
Canada
JX-594, vaccinia virus
Andrea McCart, Ontario Institute for Cancer Research
Ovarian Cancer
01/15
06/15

Download Options